These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3393256)

  • 41. [Determination of cholylglycine in alcoholic hepatopathies. Clinical usefulness].
    Pagani A; Pranzo A; Galante T
    Minerva Dietol Gastroenterol; 1985; 31(1):25-31. PubMed ID: 4000510
    [No Abstract]   [Full Text] [Related]  

  • 42. [The problems of collagen formation in chronic liver diseases].
    Iakhontova OI; Dudanova OP
    Ter Arkh; 1994; 66(2):13-7. PubMed ID: 8160135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Plasma fibronectin and alcoholic liver disease].
    Ricciardi R; Restuccia G; Chindemi G
    Quad Sclavo Diagn; 1987 Jun; 23(2):153-63. PubMed ID: 3451292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Characterization and application to collagen type IV metabolism in fibrotic liver disease.
    Schuppan D; Besser M; Schwarting R; Hahn EG
    J Clin Invest; 1986 Jul; 78(1):241-8. PubMed ID: 3722378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Serum type III procollagen peptide in tissue fibrosis].
    Maruyama K
    Rinsho Byori; 1985 Jan; 33(1):27-32. PubMed ID: 3990010
    [No Abstract]   [Full Text] [Related]  

  • 46. Ito cells and fibrogenesis in chronic alcoholic liver disease.
    González-Reimers CE; Brajín-Rodríguez MM; Santolaria-Fernández F; Diaz-Flores L; Conde-Martel A; Rodríguez-Rodríguez E; Essardas-Daryanani H
    Drug Alcohol Depend; 1992 Feb; 29(3):225-30. PubMed ID: 1559427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?
    Mutimer DJ; Bassendine MF; Kelly P; James OF
    J Hepatol; 1989 Sep; 9(2):184-9. PubMed ID: 2809158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical usefulness of serum procollagen-III-peptide in patients with solid tumor].
    Takahashi T; Takami H; Abe O; Ootake T; Kano S
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1480-6. PubMed ID: 6204598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
    Schytte S; Hansen M; Møller S; Junker P; Henriksen JH; Hillingsø J; Teisner B
    Scand J Clin Lab Invest; 1999 Dec; 59(8):627-33. PubMed ID: 10691054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II.
    Sheppard MS; Minuk GY; Bhaumick B; Bala RM
    Clin Invest Med; 1987 Mar; 10(2):49-53. PubMed ID: 3581545
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Assay of an amino propeptide of procollagen III in hepatic pathology].
    Lefrère JJ; Arrago JP; Poirier O; Najean Y
    Ann Med Interne (Paris); 1987; 138(8):667. PubMed ID: 3450217
    [No Abstract]   [Full Text] [Related]  

  • 52. [Correlation between adhesive factors of primary hemostasis and liver fibrogenesis in alcoholic live cirrhosis].
    Udvardy M; Hársfalvi J; Pósán E; Káplár M; Katona E; Rák K
    Orv Hetil; 1994 Mar; 135(10):523-6. PubMed ID: 8146008
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
    Gressner AM; Tittor W; Negwer A
    Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Amino-terminal procollagen type-III peptide and hepatic fibrogenesis].
    Castilla Cortázar A
    Med Clin (Barc); 1993 Mar; 100(11):436. PubMed ID: 8464262
    [No Abstract]   [Full Text] [Related]  

  • 55. [Chronic alcoholic liver disease. Ionized blood calcium measurements in 24 patients (author's transl)].
    Louboutin JY; Feuillu A; Bansard JY; Brissot P; Pawlotsky Y; Bourel M
    Nouv Presse Med; 1980 May; 9(24):1689-90. PubMed ID: 7465398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Markers of hepatic fibrogenesis in alcoholic patients].
    de la Maza MP; Chichester C; Hirsch S; Petermann M; Iturriaga H; Bunout D
    Rev Med Chil; 1997 Jan; 125(1):15-21. PubMed ID: 9336064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Collier J
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):384-92. PubMed ID: 18403939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between procollagen-III-peptide and the severity of esophageal varices in children with biliary atresia after Kasai operation.
    Sathienkijakarnchai P; Chongsrisawat V; Charoensapaya J; Tanprayoon T; Chandrakamol B; Suwangool P; Poovorawan Y
    Pediatr Surg Int; 2002 Jan; 18(1):32-5. PubMed ID: 11793060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
    Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
    Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Trace elements (copper, zinc, magnesium) in portal and biliary liver cirrhosis].
    Sajewicz Z; Knapik Z; Bulak Z; Rudolf M
    Wiad Lek; 1987 Dec; 40(24):1677-9. PubMed ID: 3451603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.